SPDR S&P Biotech ETF (XBI) ETF

Expense Ratio: 0.35% | AUM: 5.42B | Issuer: State Street Global Advisors

XBI Daily Price Range
XBI 52-Week Price Range

XBI - Real-Time SMART Grade™

A
Strong Buy

Overall SMART Grade

XBI has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

XBI - Profile & Info


The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.

Issuer State Street Global Advisors
Expense Ratio 0.35%
Assets Under Management (AUM) 5.42B
Underlying Index S&P Biotechnology Select Industry Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $112.46
Options? Yes
Total Holdings 137

XBI - Top Holdings

Symbol Holding Name % of Total
INO Inovio Pharmaceuticals Inc 2.03%
NVTA Invitae Corp 1.84%
NVAX Novavax Inc 1.80%
FOLD Amicus Therapeutics Inc 1.35%
OPK OPKO Health Inc 1.35%
ARWR Arrowhead Pharmaceutical 1.29%
NTRA Natera Inc 1.20%
ALKS ALKERMES PLC 1.16%
ALNY Alnylam Pharmaceuticals 1.16%
ESPR ESPERION THERA 1.16%
HALO Halozyme Therapeutics Inc 1.15%
BMRN BioMarin Pharmaceutical Inc 1.14%
EBS EMERGENT BIOSO 1.13%
RARE Ultragenyx Pharmaceutical Inc 1.13%
SAGE SAGE 1.13%
IMMU IMMUNOMEDICS 1.12%
BBIO BridgeBio Pharma Inc 1.12%
AGIO Agios Pharmaceuticals 1.11%
KPTI Karyopharm Therapeutics Inc 1.11%
TGTX TG Therapeutics Inc 1.11%
INCY INCYTE CORP 1.11%
SGEN Seattle Genetics Inc 1.10%
BPMC Blueprint Medicines Corp 1.10%
FATE FATE THERAPEUTIC 1.09%
MRTX Mirati Therapeutics Inc 1.09%
BCRX BioCryst Pharmaceuticals Inc 1.09%
CHRS Coherus BioSciences Inc 1.09%
BHVN Biohaven Pharmaceutical Holding Co. Ltd. 1.09%
DCPH DCPHRA PHRMCTC 1.08%
AMGN Amgen Inc 1.06%
VRTX Vertex Pharmaceuticals Inc 1.06%
MNTA Momenta Pharmaceuticals Inc 1.05%
NBIX Neurocrine Biosciences Inc 1.04%
FGEN FibroGen Inc. 1.04%
ABBV AbbVie Inc 1.04%
REGN Regeneron Pharmaceuticals Inc 1.04%
EXEL EXELIXIS INC 1.04%
ACAD ACADIA Pharmaceuticals Inc 1.04%
APLS Apellis Pharmaceuticals 1.03%
GILD GILEAD SCI 1.03%
UTHR United Therapeutics Corp 1.03%
EDIT EDITAS MEDICIN 1.02%
MRNA Moderna Inc 1.02%
PTCT PTC Therapeutics Inc 1.01%
ALXN Alexion Pharmaceuticals 1.01%
ARNA Arena Pharmaceuticals 1.01%
LGND Ligand Pharmaceuticals Inc 1.01%
ALLO Allogene Therapeutics 1.01%
EXAS EXACT SCIENCES 1.00%
INSM Insmed Inc 0.99%
IONS Ionis Pharmaceuticals 0.99%
SRPT Sarepta Therapeutics Inc 0.99%
GBT Global Blood Therapeutics Inc 0.99%
XLRN ACCELERON PHARMA INC 0.98%
CLVS Clovis Oncology Inc. 0.98%
KRTX Karuna Therapeutics Inc. 0.97%
BIIB BIOGEN INC 0.94%
ALLK Allakos Inc 0.94%
IRWD Ironwood Pharmac 0.94%
BLUE BLUEBIRD BIO INC 0.94%
IOVA Iovance Biotherapeutics Inc 0.91%
MDGL Madrigal Pharmaceuticals Inc 0.88%
CCXI Chemocentryx Inc. 0.87%
AIMT Aimmune Therapeutics Inc 0.86%
CDNA CareDx Inc 0.83%
TWST Twist Bioscience Corp 0.82%
RGNX Regenxbio Inc 0.81%
SRNE Sorrento Therapeutics Inc 0.78%
BTAI BioXcel Therapeutics Inc 0.76%
ADVM ADVERUM BIOT O 0.74%
PRNB Principia Biopharma Inc 0.72%
DRNA DICERNA PHARMA 0.72%
TPTX Turning Point Therapeutics Inc 0.67%
SGMO Sangamo Therapeutics Inc 0.66%
KOD Kodiak Sciences Inc 0.66%
XNCR Xencor Inc 0.65%
PTLA Portola Pharmaceuticals Inc 0.64%
ICPT Intercept Pharmaceuticals Inc 0.63%
MYGN Myriad Genetics Inc 0.62%
EPZM EPIZYME INC 0.61%
AKBA Akebia Therapeutics Inc 0.60%
VCYT Veracyte Inc 0.58%
HRTX Heron Therapeutics Inc 0.55%
ATRA Atara Biotherapeutics 0.54%
DVAX DYNAVAX TECHNO 0.54%
CYTK Cytokinetics Inc 0.53%
NTLA Intellia Therapeutics Inc 0.53%
PBYI Puma Biotechnology Inc 0.52%
CVM CEL-SCI Corporation 0.52%
CNST Constellation Pharmaceuticals Inc 0.48%
IMGN IMMUNOGEN INC 0.48%
VCEL Vericel Corp 0.47%
ATHX Athersys Inc 0.43%
ENTA ENANTA PHARMAC 0.42%
DNLI Denali Therapeutics Inc 0.42%
ALEC Alector 0.42%
RDUS Radius Health Inc 0.41%
FLXN Flexion Therapeutics Inc 0.40%
CPRX Catalyst Pharmaceuticals Inc. 0.40%
RCUS ARCUS BIOSCIEN 0.40%
EGRX EAGLE PHARMACEUTICALS INC 0.40%
KDMN Kadmon Holdings Inc 0.39%
VKTX Viking Therapeutics Inc 0.39%
ANAB Anaptys Bio Inc 0.39%
VNDA Vanda Pharmaceuticals Inc 0.38%
RTRX Retrophin Inc 0.36%
KRYS Krystal Biotech Inc. 0.33%
RCKT Rocket Pharmaceuticals Inc 0.32%
YMAB Y-mAbs Therapeutics Inc 0.31%
GTHX G1 Therapeutics Inc 0.30%
TBIO Translate Bio Inc 0.30%
MGNX MacroGenics Inc 0.29%
ANIK Anika Therapeutics Inc 0.28%
ATNX Athenex 0.28%
MRSN Mersana Therapeutics Inc 0.28%
AGEN Agenus Inc 0.28%
CRBP Corbus Pharmaceuticals Holdings Inc 0.28%
IGMS IGM Biosciences Inc. 0.24%
CUE Cue Biopharma Inc 0.23%
GOSS Gossamer Bio Inc 0.22%
VIE Veolia Environnement SA 0.22%
FIXX Homology Medicines Inc 0.22%
ARDX Ardelyx Inc 0.22%
ZIOP ZIOPHARM Oncology Inc 0.22%
KURA Kura Oncology Inc. 0.21%
RYTM Rhythm Pharmaceuticals Inc 0.20%
SPPI Spectrum Pharmaceuticals Inc 0.19%
CTMX CytomX Therapeutics Inc 0.19%
VYGR Voyager Therapeutics Inc 0.18%
ASMB Assembly Biosciences Inc 0.18%
AVRO Avrobio Inc 0.17%
PDLI PDL BioPharma Inc 0.15%
PRTA Prothena Corp PLC 0.12%
70286227 STATE STREET INSTITUTIONAL LIQ STATE STR 0.12%
U.S. Dollar 0.02%
XBI SPDR S&P Biotech ETF 0.00%
004CVR03 ACHILLION PHARMACEUTICALS INC COMMON STO 0.00%

XBI - Top Stories


View All XBI News

XBI - Price/Volume Stats

Current price $112.89
Prev. close $112.89
Day low $111.95
Day high $114.28
52-week high $115.77
52-week low $62.94
Day Volume 5,053,757
Avg. volume 7,184,260
Dividend yield 0.02%

XBI - Recent Returns

1-mo 9.71%
3-mo 43.30%
6-mo 18.09%
1-year 29.47%
3-year 44.72%
5-year 41.50%
YTD 18.71%
2019 32.56%
2018 -15.28%
2017 43.77%
2016 -15.45%
2015 13.58%

XBI - Stock Chart


XBI - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular Articles



Page generated in 1.3723 seconds.